Modulating Therapeutic Activity and Toxicity of Pyrrolobenzodiazepine Antibody-Drug Conjugates with Self-Immolative Disulfide Linkers

被引：53

作者：

Pillow, Thomas H. ^{[1
]}

Schutten, Melissa ^{[1
]}

Yu, Shang-Fan ^{[1
]}

Ohri, Rachana ^{[1
]}

Sadowsky, Jack ^{[1
]}

Poon, Kirsten Achilles ^{[1
,4
]}

Solis, Willy ^{[1
,5
]}

Zhong, Fiona ^{[1
]}

Del Rosario, Geoffrey ^{[1
]}

Go, Mary Ann T. ^{[1
]}

Lau, Jeffrey ^{[1
]}

Yee, Sharon ^{[1
]}

He, Jintang ^{[1
]}

Liu, Luna ^{[1
]}

Ng, Carl ^{[1
]}

Xu, Keyang ^{[1
]}

Leipold, Douglas D. ^{[1
]}

Kamath, Amrita V. ^{[1
]}

Zhang, Donglu ^{[1
]}

Masterson, Luke ^{[2
]}

Gregson, Stephen J. ^{[2
]}

Howard, Philip W. ^{[2
]}

Fang, Fan ^{[3
]}

Chen, Jinhua ^{[3
]}

Gunzner-Toste, Janet ^{[1
]}

Kozak, Katherine K. ^{[1
]}

Spencer, Susan ^{[1
]}

Polakis, Paul ^{[1
]}

Polson, Andrew G. ^{[1
]}

Flygare, John A. ^{[1
]}

Junutula, Jagath R. ^{[1
,6
]}

机构：

[1] Genentech Inc, San Francisco, CA 94030 USA

[2] Spirogen Ltd, QMBInnovat Ctr, London, England

[3] WuXi AppTec Co Ltd, Shanghai, Peoples R China

[4] Denali Therapeut, San Francisco, CA USA

[5] Bristol Myers Squibb, Princeton, NJ USA

[6] Cellerant Therapeut, San Carlos, CA USA

来源：

MOLECULAR CANCER THERAPEUTICS | 2017年 / 16卷 / 05期

关键词：

BIOLOGICAL EVALUATION; TARGETED TREATMENT; CANCER-THERAPY; IN-VIVO; DESIGN; CHEMISTRY; SELECTION; STABILITY; LYMPHOMA; DELIVERY;

D O I：

10.1158/1535-7163.MCT-16-0641

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

A novel disulfide linker was designed to enable a direct connection between cytotoxic pyrrolobenzodiazepine (PBD) drugs and the cysteine on a targeting antibody for use in antibody-drug conjugates (ADCs). ADCs composed of a cysteine-engineered antibody were armed with a PBD using a self-immolative disulfide linker. Both the chemical linker and the antibody site were optimized for this new bioconjugation strategy to provide a highly stable and efficacious ADC. This novel disulfide ADC was compared with a conjugate containing the same PBD drug, but attached to the antibody via a peptide linker. Both ADCs had similar efficacy in mice bearing human tumor xenografts. Safety studies in rats revealed that the disulfide-linked ADC had a higher MTD than the peptide-linked ADC. Overall, these data suggest that the novel self-immolative disulfide linker represents a valuable way to construct ADCs with equivalent efficacy and improved safety. (C) 2017 AACR.

引用

页码：871 / 878

页数：8

共 50 条

[1] Self-Immolative Carbamate Linkers for CD19-Budesonide Antibody-Drug Conjugates
Marvin, Christopher C.
Hobson, Adrian D.
Mcpherson, Michael
Dunstan, Theresa A.
Vargo, Thomas R.
Hayes, Martin E.
Fettis, Margaret M.
Bischoff, Agnieszka
Wang, Lu
Wang, Lu
Hernandez Jr, Axel
Jia, Ying
Oh, Jason Z.
Tian, Yu
BIOCONJUGATE CHEMISTRY, 2023, 34 (10) : 1835 - 1850
[2] A mild phenoxysilyl linker for self-immolative release of antibody-drug conjugates
Wei, Ding
Mao, Yurong
Wang, Huihui
Qu, Siqi
Chen, Jiakang
Li, Jiusheng
Jiang, Biao
Chen, Hongli
CHINESE CHEMICAL LETTERS, 2023, 34 (05)
[3] Self-immolative Linkers in Prodrugs and Antibody Drug Conjugates in Cancer Treatment
Edupuganti, Veera V. Shivaji R.
Tyndall, Joel D. A.
Gamble, Allan B.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2021, 16 (04) : 479 - 497
[4] Pyrrolobenzodiazepine Dimer Antibody-Drug Conjugates: Synthesis and Evaluation of Noncleavable Drug-Linkers
Gregson, Stephen J.
Masterson, Luke A.
Wei, Binqing
Pillow, Thomas H.
Spencer, Susan D.
Kang, Gyoung-Dong
Yu, Shang -Fan
Raab, Helga
Lau, Jeffrey
Li, Guangmin
Phillips, Gail D. Lewis
Gunner-Toste, Janet
Safina, Brian S.
Ohri, Rachana
Darwish, Martine
Kozak, Katherine R.
dela Cruz-Chuh, Josefa
Poison, Andrew
Flygare, John A.
Howard, Philip W.
JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (23) : 9490 - 9507
[5] The Methylene Alkoxy Carbamate Self-Immolative Unit: Utilization for the Targeted Delivery of Alcohol-Containing Payloads with Antibody-Drug Conjugates
Kolakowski, Robert V.
Haelsig, Karl T.
Emmerton, Kim K.
Leiske, Chris I.
Miyamoto, Jamie B.
Cochran, Julia H.
Lyon, Robert P.
Senter, Peter D.
Jeffrey, Scott C.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2016, 55 (28) : 7948 - 7951
[6] Exploration of Pyrrolobenzodiazepine (PBD)-Dimers Containing Disulfide-Based Prodrugs as Payloads for Antibody-Drug Conjugates
Pei, Zhonghua
Chen, Chunjiao
Chen, Jinhua
dela Cruz-Chuh, Josefa
Delarosa, Reginald
Deng, Yuzhong
Fourie-O'Donohue, Aimee
Figueroa, Isabel
Guo, Jun
Jin, Weiwei
Khojasteh, S. Cyrus
Kozak, Katherine R.
Latifi, Brandon
Lee, James
Li, Guangmin
Lin, Eva
Liu, Liling
Lu, Jiawei
Martin, Scott
Ng, Carl
Trung Nguyen
Ohri, Rachana
Phillips, Gail Lewis
Pillow, Thomas H.
Rowntree, Rebecca K.
Stagg, Nicola J.
Stokoe, David
Ulufatu, Sheila
Verma, Vishal A.
Wai, John
Wang, Jing
Xu, Keyang
Xu, Zijin
Yao, Hui
Yu, Shang-Fan
Zhang, Donglu
Dragovich, Peter S.
MOLECULAR PHARMACEUTICS, 2018, 15 (09) : 3979 - 3996
[7] Catalytic Cleavage of Disulfide Bonds in Small Molecules and Linkers of Antibody-Drug Conjugates
Zhang, Donglu
Fourie-O'Donohue, Aimee
Dragovich, Peter S.
Pillow, Thomas H.
Sadowsky, Jack D.
Kozak, Katherine R.
Cass, Robert T.
Liu, Liling
Deng, Yuzhong
Liu, Yichin
Hop, Cornelis E. C. A.
Khojasteh, S. Cyrus
DRUG METABOLISM AND DISPOSITION, 2019, 47 (10) : 1156 - 1163
[8] Water-soluble prodrugs of paclitaxel containing self-immolative disulfide linkers
Gund, Machhindra
Khanna, Amit
Dubash, Nauzer
Damre, Anagha
Singh, Kishore S.
Satyam, Apparao
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (01) : 122 - 127
[9] Development of Novel Quaternary Ammonium Linkers for Antibody-Drug Conjugates
Burke, Patrick J.
Hamilton, Joseph Z.
Pires, Thomas A.
Setter, Jocelyn R.
Hunter, Joshua H.
Cochran, Julia H.
Waight, Andrew B.
Gordon, Kristine A.
Toki, Brian E.
Emmerton, Kim K.
Zeng, Weiping
Stone, Ivan J.
Senter, Peter D.
Lyon, Robert P.
Jeffrey, Scott C.
MOLECULAR CANCER THERAPEUTICS, 2016, 15 (05) : 938 - 945
[10] Linkers Having a Crucial Role in Antibody-Drug Conjugates
Lu, Jun
Jiang, Feng
Lu, Aiping
Zhang, Ge
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (04)

← 1 2 3 4 5 →